第一作者

• Huang CC, Yeh HY, Lin R, Liao TL, Shen HC, Yang YY, Lin HC. Inhibition of visceral adipose tissue-derived pathogenic signals by activation of adenosine A2AR improves hepatic and cardiac dysfunction of NASH mice. Am J Physiol Gastrointest Liver Physiol. 2024 Jan 22. [IF 3.9]

第一加通訊作者

• Huang CC*, Yeh HY, Lin R, Liao TL, Shen HC, Yang YY, Lin HC. Inhibition of visceral adipose tissue-derived pathogenic signals by activation of adenosine A2AR improves hepatic and cardiac dysfunction of NASH mice. Am J Physiol Gastrointest Liver Physiol. 2024 Apr 1. [IF 4.5]

共同作者

• Yeh HY, Wu HH, Shen HC, Li TH, Yang YY, Lee KC, Lin YH, Huang CC, Hou MC. Optimal body mass index for protecting middle-aged and elderly patients with fatty liver from future fractures. Endocr Connect. 2024 May 1. [IF 2.6]
• Shen HC, Pan MH, Huang CJ, Yeh HY, Yang HI, Lin YH, Huang CC, Lee KC, Yang YY, Hou MC. Multiple genetic polymorphisms are associated with the risk of metabolic syndrome, fatty liver, and airflow limitation: A Taiwan Biobank study. Gene. 2024 Jun 10. [IF 2.6]
• Shen HC, Pan MH, Huang CJ, Yeh HY, Yang HI, Lin YH, Huang CC, Lee KC, Yang YY, Hou MC. Multiple genetic polymorphisms are associated with the risk of metabolic syndrome, fatty liver, and airflow limitation: A Taiwan Biobank study. Gene. 2024 Nov 15. [IF 2.6]
• Lin YH, Wang CH, Huang YH, Shen HC, Wu WK, Yeh HY, Huang CC, Su CW, Yang YY, Wu MS, Lin HC, Hou MC. Models incorporating physical, laboratory and gut metabolite markers can be used to predict severe hepatic steatosis in MAFLD patients. Kaohsiung J Med Sci. 2024 Nov 4. [IF 2.7]